|
GINMU >
Browsing by Author Sho, Masayuki
Showing results 1 to 5 of 5
Issue Date | Title | Author(s) |
Sep-2024 | Clinical impact of carbonic anhydrase 9 expression on neoadjuvant chemoradiotherapy in pancreatic ductal adenocarcinoma | Terai, Taichi; Nishiwada, Satoshi; Nagai, Minako; Nakamura, Kota; Kohara, Yuichiro; Yasuda, Satoshi; Matsuo, Yasuko; Doi, Shunsuke; Sakata, Takeshi; Kumada, Hirokimi; Watanabe, Mizuki; Sho, Masayuki |
Mar-2025 | Intra-arterial Therapy Using Micellar Nanoparticles Incorporating SN-38 in a Rat Pancreatic Tumor Model | Maeda, Shinsaku; Sato, Takeshi; Nishiofuku, Hideyuki; Toyoda, Shohei; Taiji, Ryosuke; Matsumoto, Takeshi; Chanoki, Yuto; Tachiiri, Tetsuya; Kunichika, Hideki; Sho, Masayuki; Tanaka, Toshihiro |
Apr-2023 | Lauric acid overcomes hypoxia-induced gemcitabine chemoresistance in pancreatic ductal adenocarcinoma | Takagi, Tadataka; Fujiwara-Tani, Rina; Mori, Shiori; Kishi, Shingo; Nishiguchi, Yukiko; Sasaki, Takamitsu; Ogata, Ruiko; Ikemoto, Ayaka; Sasaki, Rika; Ohmori, Hitoshi; Luo, Yi; Bhawal, Ujjal Kumar; Sho, Masayuki; Kuniyasu, Hiroki |
25-May-2022 | Overexpression of microRNA-345 Affects the Invasive Capacity of Pancreatic Ductal Adenocarcinoma Cell Lines by Suppressing MUC1 and TJP2 Expression | Tatsumi, Shigenobu; Fujii, Tomomi; Sugimoto, Aya; Sekita-Hatakeyama, Yoko; Morita, Kohei; Uchiyama, Tomoko; Itami, Hiroe; Takeda, Maiko; Yamazaki, Masaharu; Sho, Masayuki; Ohbayashi, Chiho |
2022 | Preclinical evaluation of pentagamavunone‑1 as monotherapy and combination therapy for pancreatic cancer in multiple xenograft models | Kamitani, Naoki; Yoneda‑Kato, Noriko; Kato, Jun‑ya; Sho, Masayuki |
Showing results 1 to 5 of 5
|